NTUS - Natus Medical EPS in-line beats on revenue; provides outlook

Natus Medical (NTUS): Q1 Non-GAAP EPS of $0.16 in-line; GAAP EPS of $0.07 beats by $0.04.Revenue of $114.9M (+5.0% Y/Y) beats by $3.5M.Financial Guidance: For the second quarter 2021, the Company's revenue is expected to be between $112.0 million and $116.0 million vs. consensus of $114.00M and non-GAAP earnings per share is expected to be between $0.26 and $0.32 vs. consensus of $0.25For the full year 2021, the Company's revenue is expected to be between $463.5 million and $473.5 million vs. consensus of $466.00M and non-GAAP earnings per share is expected to be between $1.11 and $1.26 vs. consensus of $1.18.Press Release

For further details see:

Natus Medical EPS in-line, beats on revenue; provides outlook